187 results on '"Yuen, Sam"'
Search Results
2. Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
3. Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
4. Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
5. Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson’s disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial
6. Polatuzumab vedotin, venetoclax, and an anti‐CD20 monoclonal antibody in relapsed/refractory B‐cell non‐Hodgkin lymphoma.
7. Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma
8. Prevalence of sleep disturbances during COVID-19 outbreak in an urban Chinese population: a cross-sectional study
9. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
10. Massage therapy in infants and children under 5 years of age: protocol for an overview of systematic reviews
11. Automated Network Planning for Industrial Wireless Mesh Networks.
12. High Reliability, Low Latency and Cost Effective Network Planning for Industrial Wireless Mesh Networks.
13. Planting a Seed of Experience – Long Term Effects of a Co-curricular Ecogarden-Based Program in Higher Education in Hong Kong
14. List of Contributors
15. Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study
16. Phytocapping of Landfills
17. Energy Efficient Low-Complexity Symbol-by-Symbol GMSK Demodulator for BAN.
18. Demand Bidding Program and Its Application in Hotel Energy Management.
19. Low-Complexity Iterative Synchronization for A Robust Receiver at Low Signal-to-Noise Ratios.
20. Low-Complexity Iterative Carrier Synchronization for Short Packet Turbo Receiver.
21. Modulation and Code Mapping Scheme for High Rate Transmission for IEEE 802.15.4b.
22. A Low Complexity Mapping and Modulation Scheme for IEEE 802.15.4b.
23. Cyclic Odd Bit Inversion Code Mapping and Modulation Scheme for IEEE 802.15.4b 915MHz Wireless Personal Area Networks.
24. Iterative Decoding with Blind Channel Estimation in a SIMO FIR Channel.
25. Low Complexity 16-Ary Ternary Orthogonal Keying for UWB Communications.
26. Turbo Coding with Blind Channel Estimation in a SIMO FIR Channel.
27. UWB ranging with energy detectors using ternary preamble sequences.
28. A cyclic odd bit inversion code mapping and modulation scheme for the IEEE 802.15.4b 868 MHz band.
29. Performance Analysis of Channel Coding Schemes with Blind Channel Estimation.
30. Effects of location management signaling load on the forward link throughput of UMTS-FDD systems.
31. Zanubrutinib plus obinutuzumab (ZO) versus obinutuzumab (O) monotherapy in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Primary analysis of the phase 2 randomized ROSEWOOD trial.
32. An Asymmetrical QPSK/OOK Transceiver SoC and 15: 1 JPEG Encoder IC for Multifunction Wireless Capsule Endoscopy.
33. Additional file 2 of Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson���s disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial
34. Additional file 1 of Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson���s disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial
35. Noise-robust feedforward synchronisation for resource-constrained Gaussian minimum shift keying system in wireless body area network.
36. High Reliability, Low Latency and Cost Effective Network Planning for Industrial Wireless Mesh Networks
37. A Sustainable Approach for Hydraulic Control of Landfills Using Quarry Scalpings and Native Plants
38. The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A plus CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
39. TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
40. Oral Abstract: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
41. Poster: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
42. A Low Complexity Modulation and Code Mapping Scheme for High Rate Transmission in the 915 MHz Band for IEEE 802.15.4b.
43. Planting a Seed of Experience – Long Term Effects of a Co-curricular Ecogarden-Based Program in Higher Education in Hong Kong
44. Additional file 2 of Massage therapy in infants and children under 5 years of age: protocol for an overview of systematic reviews
45. ECHELON-2 (NCT01777152), a randomized, double-blind, phase 3 study of brentuximab vedotin plus cyclophosphamide doxorubicin and prednisone versus cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with CD30-positive peripheral T-cell lymphoma: 5-year results
46. Additional file 1 of Massage therapy in infants and children under 5 years of age: protocol for an overview of systematic reviews
47. Polatuzumab vedotin + obinutuzumab + venetoclax in patients with relapsed/refractory (R/R) follicular lymphoma (FL): Primary analysis of a phase 1b/2 trial.
48. The Echelon-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
49. Polatuzumab Vedotin Plus Venetoclax with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Primary Efficacy Analysis of a Phase Ib/II Study
50. Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.